AsiaTIDES Oligonucleotide & Peptide Therapeutics Presentation: Utilising NMR for Oligonucleotide Characterisation

During AsiaTIDES: Oligonucleotide & Peptide Therapeutics, meet our experts to learn more about our oligonucleotide analytical development services. Booth 11, 26 -28 February 2019, Tokyo, Japan

During AsiaTIDES: Oligonucleotide & Peptide Therapeutics 2019, Intertek will present on analytical development strategies which help to accelerate oligonucleotide product development from early characterisation to late-stage development & commercialization. Meet our team at Booth 11. Contact us to arrange a meeting during AsiaTIDES.

PRESENTATION: 
Oligonucleotide Characterisation by NMR 
27th FEB 2019 - 15.30pm
An overview of NMR techniques for oligonucleotide analysis, including a discussion on how NMR can be used in place of more conventional techniques for melting temperature calculation, the challenges presented by NMR and a reflection on regulatory aspects.

Expert: Thomas Brown, Senior Analyst (Oligonucleotide Services), Intertek Pharmaceutical Services
Email oligos@intertek.com to request a copy of the presentation to receive after the event.


RESOURCES:
Case Study: Identification Testing by Accurate Mass and MS/MS Sequencing
Case Study: Oligonucleotide Identification, Assay and Impurities
White Paper: Analytical Strategies for Quality Control of Oligonucleotide Therapeutics

 

With a growing global development pipeline of oligonucleotide therapeutics to treat a variety of disease targets, overcoming the challenges of innovation, regulatory authorization, production and the inherent complexity of oligos is critical to success. Contact our experts in oligonucleotide analysis and bioanalysis, to discuss our regulatory-driven, phase-appropriate characterization and biophysical analysis in support of CMC programs which GMP and CMC laboratory services, pharmaceutical analysis, quality control analysis, elemental impurities, extractables and leachables, stability programs, inhalation drug development, method development and method validation will be available to review your challenges and discuss and how our unrivalled expertise can help you to accelerate the development timelines. 

 

Need help or have a question? +1 800 967 5352
 

Need help or have a question?

+1 800 967 5352
EMEA UK:
+44 161 721 5247
Switzerland:
+41 61 686 4800
 
 
 
 
 

Explore Our Pharmaceutical Services

Intertek Pharmaceutical Brochure 2017
Custom Extractables and Leachables Solutions Brochure